The Early Rehabilitation Program in Post-LT Pts
- Conditions
- ICU-acquired Weakness
- Registration Number
- NCT03529656
- Lead Sponsor
- Asan Medical Center
- Brief Summary
The purpose of this study is to determine whether an early rehabilitation program for immediate liver transplant patients is safe and effective in preventing critical care illness and intensive care unit acquired weakness.
- Detailed Description
Patients with liver transplantation (LT) have poor general condition before surgery and require ICU care for a certain period. For those patients, the side effects of ICU care such as intensive care unit-acquired weakness (ICU-AW), critical illness polyneuropathy (CIP) are well known. Therefore, we access the safety and efficacy of early rehabilitation program (ERP) in liver transplant recipients.
Patients were retrospectively selected for the Pre-ERP group (2014.05-2014.10) and for the Post-ERP group (2015.10-2016.03). During the period of 6 months, 136 patients and 100 patients underwent LT, and 65, 62 patients were enrolled after exclusion. Forty patients from the each group were compared after propensity score matching (PSM).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 236
- immediate post liver transplant patients
- patients who transferred to sub-ICU within 72 hours re-liver transplantation case wound, mental problem post op bleeding unstable vital
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method ventilator day (days) up to 60 days ICU day (days) up to 60 days
- Secondary Outcome Measures
Name Time Method hospital readmission rate after surgery (%) 1 year follow up from the surgery 1 year mortality rate (%) 1 year follow up from the surgery Time to start rehabilitation from ICU admission (days) up to 2 weeks in-hospital LOS (days) up to 24 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.